Royal Infirmary of Edinburgh Clinical Research Facility
Edinburgh, EH16 4SA, United Kingdom
NCT Number: NCT01805063
Firefighters are at increased risk of death from heart attacks when compared to other emergencyy service professionals whose jobs involve similar components such as emergency call-outs and shift work. In the largest analysis of cause of death amongst on-duty firefighters, firefighter deaths were classified according to the duty performed during the onset of symptoms or immediately prior to any sudden death. The majority of deaths due to a cardiovascular cause (i.e. heart attack) occurred during fire suppression whilst this activity represented a relatively small amount of a firefighters professional time. There was also a risk of death associated with other duties such as emergency non-fire response and physical exertion.
The investigators hypothesize that participation in active fire-fighting duties impairs blood vessel function and increases blood clot formation when compared with non-fire-fighting activities. In this study, healthy career firefighters will be assessed after three periods of duty: fire-suppression, emergency response without fire suppression and following a sedentary shift. The investigators will take blood samples to measure platelet activity (platelets are the particles in blood that help blood clot) and will examine how blood clots outside of the body. The investigators will then perform studies placing small needles in the arm to assess blood vessel function following these duties. By undertaking this comprehensive assessment of blood, blood vessel and heart function the investigators hope to understand the mechanisms whereby the risk of a heart attack, fatal or otherwise, is posed throughout these distinct duties that firefighters undertake on a daily basis.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Edinburgh, EH16 4SA, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).
Other names: BK, SNP, ACh, VP
Ex-vivo assessment of thrombus formation using the Badimon Chamber
Time frame: up to 12 hours after exposure
Time frame: up to 12 hours after exposure
Time frame: During forearm study, up to 12 hours after exposure
University of Edinburgh
Other
Effect of Fire Suppression and Emergency Duties on Vascular Function in Firefighters
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01813032
Atherothrombosis, Cardiovascular Diseases
Edinburgh, United Kingdom
View Trial DetailsNCT01812317
Atherothrombosis, Cardiovascular Diseases
Edinburgh, United Kingdom
View Trial DetailsNCT04550026
Blood Markers, Cardiovascular Diseases
Danderyd, Stockholm County, Sweden
View Trial DetailsNCT01495325
Cardiovascular Diseases, Embolism and Thrombosis
Umeå, Västerbotten County, Sweden
View Trial Details